Generation Bio Co Stock Probability of Future Stock Price Finishing Over 18.29

GBIO Stock  USD 1.06  0.04  3.64%   
Generation Bio's future price is the expected price of Generation Bio instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Generation Bio Co performance during a given time horizon utilizing its historical volatility. Check out Generation Bio Backtesting, Generation Bio Valuation, Generation Bio Correlation, Generation Bio Hype Analysis, Generation Bio Volatility, Generation Bio History as well as Generation Bio Performance.
  
At this time, Generation Bio's Price Book Value Ratio is very stable compared to the past year. As of the 24th of December 2024, Price To Book Ratio is likely to grow to 0.55, while Price To Sales Ratio is likely to drop 19.69. Please specify Generation Bio's target price for which you would like Generation Bio odds to be computed.

Generation Bio Target Price Odds to finish over 18.29

The tendency of Generation Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 18.29  or more in 90 days
 1.06 90 days 18.29 
close to zero percent
Based on a normal probability distribution, the odds of Generation Bio to move over $ 18.29  or more in 90 days from now is close to zero percent (This Generation Bio Co probability density function shows the probability of Generation Stock to fall within a particular range of prices over 90 days) . Probability of Generation Bio price to stay between its current price of $ 1.06  and $ 18.29  at the end of the 90-day period is under 95 .
Given the investment horizon of 90 days the stock has the beta coefficient of 3.44 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Generation Bio will likely underperform. Additionally Generation Bio Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Generation Bio Price Density   
       Price  

Predictive Modules for Generation Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Generation Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.071.316.20
Details
Intrinsic
Valuation
LowRealHigh
0.193.738.62
Details
7 Analysts
Consensus
LowTargetHigh
10.7411.8013.10
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.25-0.17-0.08
Details

Generation Bio Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Generation Bio is not an exception. The market had few large corrections towards the Generation Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Generation Bio Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Generation Bio within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-1.37
β
Beta against Dow Jones3.44
σ
Overall volatility
0.54
Ir
Information ratio -0.27

Generation Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Generation Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Generation Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Generation Bio generated a negative expected return over the last 90 days
Generation Bio has some characteristics of a very speculative penny stock
Generation Bio has high historical volatility and very poor performance
Generation Bio has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 5.9 M. Net Loss for the year was (126.61 M) with profit before overhead, payroll, taxes, and interest of 0.
Generation Bio Co currently holds about 301.17 M in cash with (52.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 83.0% of the company shares are owned by institutional investors

Generation Bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Generation Stock often depends not only on the future outlook of the current and potential Generation Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Generation Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding64.5 M
Cash And Short Term Investments264.4 M

Generation Bio Technical Analysis

Generation Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Generation Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Generation Bio Co. In general, you should focus on analyzing Generation Stock price patterns and their correlations with different microeconomic environments and drivers.

Generation Bio Predictive Forecast Models

Generation Bio's time-series forecasting models is one of many Generation Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Generation Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Generation Bio

Checking the ongoing alerts about Generation Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Generation Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Generation Bio generated a negative expected return over the last 90 days
Generation Bio has some characteristics of a very speculative penny stock
Generation Bio has high historical volatility and very poor performance
Generation Bio has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 5.9 M. Net Loss for the year was (126.61 M) with profit before overhead, payroll, taxes, and interest of 0.
Generation Bio Co currently holds about 301.17 M in cash with (52.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 83.0% of the company shares are owned by institutional investors
When determining whether Generation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Generation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Generation Bio Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Generation Bio Co Stock:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.19)
Revenue Per Share
0.28
Quarterly Revenue Growth
2.52
Return On Assets
(0.19)
Return On Equity
(0.86)
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.